Pipeline GO has built a portfolio of super-clean tumor antigens and antibodies against them that covers most major solid tumor indications where unmet needs remain high – and we’re continuing to expand. Program Target Indications Partnership GO-M100 Multiple Solid Tumors GO-M400 Multiple Solid Tumors Partner GO-L100 All Breast Cancers GO-ECM1 Solid Tumor Stroma Targeting GO-R441 Multiple Solid Tumors Partner GO-R800 Multiple Solid Tumors GO-R170 Multiple Solid Tumors GO-R990 Multiple Solid Tumors
